22nd Century Group Q3 Revenue: Tobacco and Cannabis Products

Nov.09.2022
22nd Century Group Q3 Revenue: Tobacco and Cannabis Products
22nd Century Group's Q3 revenue from tobacco products was $11.5 million, with a 47.7% increase from 2021. They also generated $7.8 million from cannabis-related products.

In the third quarter, 22nd Century Group's revenue from tobacco-related products reached $11.5 million, a 47.7% increase from 2021. This was mainly attributed to an increase in the number of boxes sold, price hikes, and a favorable combination of filtered cigars and cigarettes (including exported cigarettes).


The revenue from marijuana/marijuana-related products was $7.8 million, compared to $0 in the same quarter last year.


During this quarter, the company expanded its distribution of VLN nicotine-reducing cigarettes, accelerating sales in Colorado and Illinois, while also launching the brand in the "Four Corners" states of Arizona, Utah, and New Mexico.


In the past few months, 22nd Century has made significant progress in reducing nicotine in tobacco and the cannabis/marijuana industry," said James A. Mish, CEO of 22nd Century, in a statement. "Our VLN product release has expanded from a special pilot in Chicago to five states. We plan to expand this base to as many as 18 states in the next 12 months.


By doing so, we will be able to enter more than half of the $80 billion US tobacco market and put ourselves in a favorable position in most, if not all, states that have enacted MRTP (Modified Risk Tobacco Product) consumption tax provisions, benefiting our unique product authorization. Even capturing just 1% of the market share (which we believe is highly achievable based on our pilot results) would be a game-changer for our revenue stream.


The FDA continues to drive its interest in the transformative policy of reduced nicotine and menthol, and 22nd Century is at the forefront of this opportunity with our unique MRTP authorization for a 95% reduction in nicotine combustible cigarettes and years of clinical research backing the benefits of our product.


Statement:


This article is compiled based on information from third-party sources and is intended solely for industry exchanges and learning.


This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the authenticity and accuracy of the content. The translation of this article is only intended for industry discussion and research.


Due to limitations in the translation process, the compiled article may not accurately convey the same meaning as the original text. Please refer to the original article for accuracy.


2FIRSTS aligns completely with the Chinese government on any domestic, Hong Kong, Macau and Taiwan-related, as well as foreign-related, statements and stances.


The copyright of compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

From Partnership to Acquisition: Why KT&G Is Betting on the Global Nicotine Pouch Market
From Partnership to Acquisition: Why KT&G Is Betting on the Global Nicotine Pouch Market
As global competition in the nicotine pouch market accelerates, Korea’s tobacco major KT&G has moved with a “Partnership + Acquisition” strategy, teaming up with Altria to acquire Nordic pouch maker Another Snus Factory (brand “LOOP”). Why deploy capital now, and why take this route? Drawing on company disclosures, regulatory monitoring and on-site observations from InterTabac Dortmund, 2Firsts analyzes KT&G’s strategic calculus and the signals behind this move.
Nov.05
Belarus Proposes Criminal Liability for Selling Vapes to Minors
Belarus Proposes Criminal Liability for Selling Vapes to Minors
Belarus is discussing the introduction of criminal liability for selling vapes and related nicotine-containing products to minors. During a meeting of the expert council, a draft law regulating tobacco and non-tobacco nicotine products received support from most members.
Dec.15 by 2FIRSTS.ai
Singapore media: Relx-linked firm Hellow SG struck off and office closed in Singapore
Singapore media: Relx-linked firm Hellow SG struck off and office closed in Singapore
According to The Straits Times, after Singapore strengthened anti-vaping enforcement from September 2025, Relx International-linked entity Hellow SG voluntarily applied for deregistration and was officially struck off by ACRA on September 30, closing its local office. The company reportedly undertook regional business support and operated quietly.
Nov.03 by 2FIRSTS.ai
China Further Tightens E-Cigarette Capacity and Investment Controls, Supply Chain Faces Stronger Regulation and Accelerated Shakeout
China Further Tightens E-Cigarette Capacity and Investment Controls, Supply Chain Faces Stronger Regulation and Accelerated Shakeout
China is tightening controls over e-cigarette production capacity and investment as regulators move to curb disorderly competition and address oversupply risks, a new policy framework released on December 25 shows, signaling stronger oversight and a faster shakeout across the country’s e-cigarette supply chain, according to first-hand reporting by 2Firsts.
Dec.25
BAT Expects Around 2% Revenue and Operating Profit Growth in FY25
BAT Expects Around 2% Revenue and Operating Profit Growth in FY25
British American Tobacco (BAT) reaffirmed its 2026 guidance while announcing a £1.3 billion (approximately USD 1.65 billion) share buyback for FY26. The company expects around 2% growth in revenue and adjusted profit from operations for FY25. Accelerating New Category growth, driven by Velo Plus and improving U.S. Vuse performance, is expected to deliver double-digit H2 revenue growth.
Dec.09 by 2FIRSTS.ai
FDA CTP Acting Director  Supports Expanding Authorized Flavored E-Cigs and Legal Marketplace
FDA CTP Acting Director Supports Expanding Authorized Flavored E-Cigs and Legal Marketplace
At the FDLI Tobacco and Nicotine Policy Conference, FDA CTP Acting Director Bret Koplow spoke in favor of promoting tobacco harm reduction to reduce smoking. He backed a legal marketplace for authorized reduced-risk products, potential expansion of flavored e-cigs, and faster FDA reviews to ensure a strong, regulated market.
Oct.29 by 2FIRSTS.ai